Finance ❯ Investments ❯ Stock Market
Investor Losses Investor Rights Investor Protection Investor Relations Class Action Lawsuits Market Analysis Market Regulation Market Performance Fraudulent Practices Shareholder Equity
Filings claim the company downplayed FDA objections to relacorilant by touting its approval prospects.